unlike the first, there is no inflammation present. The cartilage in the joint is damaged and will eventually degenerate. Pain will slightly be felt when the person gets up but this will hurt later on during the day.
Osteoarthritis can either be primary or secondary. When it is primary, it is often associated with age. It is similar to a car where the parts have to be replaced due to wear and tear. Doctors consider this to be normal as people grow older.
The secondary type is often associated with something else that has caused this to happen. Some of these factors are an injury that took place, heredity, obesity and bone density.
Osteoarthritis can be treated with medication, exercise, weight control, joint protection, physical and occupational therapy. This is done to relieve the pain and slow the progression of the disease.
Both of these are caused by different things. The common thing between these 2 types is that joint pain can happen anywhere in the body.
Given the many medications available to treat this disease, the patient has to be aware of the side effects of each before choosing which one to use. The doctor should explain these to the person in order to make the right decision.
Arthritis and it's different forms will not go away. Since this is an insurable disease, the best thing that the doctor and others can do until a cure if found is to help the patient ease the pain the slow the growth of the disease.
About the author:
Robert Thatcher is a freelance publisher based in Cupertino, California. He publishes articles and reports in various ezines and provides arthritis resources on www.your-arthriti s-resources.info.
Written By: Robert Thatcher

IMPORTANT: Bing News RSS feed has moved!
<table bgColor="#ffffbb" border="1px"><td>Go to the <a href="http://api.bing.com/rss.aspx?Source=News&Market=en-US&Version=2.0&Query=Arthritis">new RSS page</a> and renew your subscription.</td></table>
Alternative Therapies Offer
An estimated 50 million Americans are living with
Benitec Biopharma and Medistem Technologies Successfully Combined in Preclinical Stem Cell Therapy for Rheumatoid
Benitec Biopharma (ASX: BLT) and Medistem (PINKSHEETS: MEDS) announced today the successful treatment of rheumatoid
Too many rheumatoid
More than 40 percent of rheumatoid
Tobacco Use And Rheumatoid
Ultrasound makes
Ultrasound is transforming the way
2 in 5 Rheumatoid
Jan. 26, 2012 -- More than 40% of U.S. adults with rheumatoid